Parabilis Medicines, Inc. Common Stock (PBLS) — Working Capital to Net Assets Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Working Capital to Net Assets ratio of 113.8% as of March 2026. Working capital of $277.83 Million (current assets of $332.07 Million minus current liabilities of $54.24 Million) is measured against net assets of $244.22 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see PBLS asset base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Parabilis Medicines, Inc. Common Stock Working Capital to Net Assets (2024–2025)
This chart shows how Parabilis Medicines, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 113.8%, reflecting working capital of $277.83 Million against net assets of $244.22 Million USD. Explore PBLS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Working Capital to Net Assets for Parabilis Medicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Parabilis Medicines, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 166.0% | $-27.43 Million | $-16.52 Million | $29.36 Million | $56.79 Million | ▲ +60.1 pp |
| 2024 | 105.9% | $59.80 Million | $56.44 Million | $92.21 Million | $32.41 Million | — |